Insider buying
~$121K100K sh @ $1.21
First insider buy since Aug 2025Traded Nov 17 · filed 1 day later
Since the trade
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 2 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider buying
First insider buy since Aug 2025Traded Nov 17 · filed 1 day later
Since the trade
Bought 34% below the 52-week high, RSI 42, 9% above its 200-day average, 11 points behind the S&P 500 over 3 months
The CEO of Maxcyte paid $121K out of pocket for Maxcyte shares. It was the first purchase in 15 months. Shares held went up 21% with this purchase.
Lately at Maxcyte: it signed an important agreement on Nov 10; the stock is down 7% in 30 days.
Traded Nov 16 – Nov 18, 2026 · largest single transaction ~$6.96M
Lately at Anaptysbio: it reported its results on Nov 12; the stock is 33% below its 12-month high; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Nov 16, 2026~$3.84M · 84K sh @ $45.66
DetailsOfficial recordNov 17, 2026~$6.96M · 152K sh @ $45.66
DetailsOfficial recordNov 18, 2026~$6.43M · 138K sh @ $46.54
DetailsOfficial recordTraded Nov 16 – Nov 17, 2026 · largest single transaction ~$802K
Lately at Pampa Energy: the stock is down 22% in 30 days; insiders made 24 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Nov 17, 2026~$802K · 13K sh @ $62.41
DetailsOfficial recordNov 16, 2026~$655K · 10K sh @ $63.92
DetailsOfficial recordInsider buying
Their first buy on recordTraded Nov 17 · filed 1 day later
Since the trade −15.1% · S&P 500 −5.8% · to Nov 20
Forgent Power Solutions's Chief Accounting Officer paid $65K out of pocket for Forgent Power Solutions shares. 4 other people at Forgent Power Solutions bought some too, in the same month. Shares held went up 43% with this purchase.
Lately at Forgent Power Solutions: the stock fell 19% in one session on Nov 5 with press coverage; it reported its results on Nov 12; the stock is down 43% in 30 days.
Insider buying
Traded Nov 16 · filed 2 days later
Since the trade +12.9% · S&P 500 −6.8% · to Nov 20
Bought 22% below the 52-week high, RSI 47, 19% above its 200-day average
The CEO of Team paid $96K out of pocket for Team shares. 2 other people at Team bought some too, in the same month. Shares held went up 8% with this purchase.
Lately at Team: the stock rose 17% in one session on Nov 12 around a company release; it reported its results on Nov 12; the stock is up 6% in 30 days.
Insider buying
4 insiders in a week, 2nd time since 2021Traded Nov 17 · filed 1 day later
Since the trade +1.3% · S&P 500 −5.8% · to Nov 20
Bought 66% below the 52-week high, RSI 41, 44% under its 200-day average, 35 points behind the S&P 500 over 3 months
Drilling Tools International's Vice President of Sales paid $46K out of pocket for Drilling Tools International shares. 6 other people at Drilling Tools International bought some too, in the same month. Shares held went up 22% with this purchase.
Lately at Drilling Tools International: it reported its results on Nov 5; the stock is down 14% in 30 days; insiders made 14 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
3 insiders in a week, 3rd time since 2022Traded Nov 17 · filed 1 day later
Since the trade +12.2% · S&P 500 −5.8% · to Nov 20
Bought at the 52-week low, RSI 28, 44% under its 200-day average, 43 points behind the S&P 500 over 3 months
The CEO of Opal Fuels paid $45K out of pocket for Opal Fuels shares. 3 other people at Opal Fuels bought some too, in the same month. Shares held went up 7% with this purchase.
Lately at Opal Fuels: it reported its results on Nov 9; the stock is down 16% in 30 days; insiders made 11 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 16 · filed 2 days later
Since the trade −1.7% · S&P 500 −6.8% · to Nov 20
Bought 24% below the 52-week high, RSI 47, 3% above its 200-day average
The CEO of Biglari paid $1.73M out of pocket for Biglari shares.
Lately at Biglari: the stock rose 16% in one session on Nov 9 with press coverage; it reported its results on Nov 6; the stock is down 14% in 30 days.
Insider buying
Traded Nov 17 · filed 1 day later
Since the trade −12.3% · S&P 500 −5.8% · to Nov 20
The CEO of Vivopower paid $554K out of pocket for Vivopower shares. Shares held went up 9% with this purchase.
Lately at Vivopower: the stock fell 27% in one session on Nov 3 with press coverage; the stock is down 25% in 30 days.
Insider buying
Largest insider buy since 2022Traded Nov 17 · filed 1 day later
Since the trade +10.2% · S&P 500 −5.8% · to Nov 20
Bought 70% below the 52-week high, RSI 44, 29% under its 200-day average
A major shareholder of Pasithea Therapeutics paid $411K out of pocket for Pasithea Therapeutics shares. Shares held went up 19% with this purchase.
Lately at Pasithea Therapeutics: the stock is 67% below its 12-month high; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 17 · filed 1 day later
Since the trade −2.3% · S&P 500 −5.8% · to Nov 20
Bought within 5% of the 52-week low, RSI 38, 8% under its 200-day average
A First Financial Bankshares director paid $51K out of pocket for First Financial Bankshares shares. 3 other people at First Financial Bankshares bought some too, in the same month. It was the first purchase in 8 months.
Lately at First Financial Bankshares: it reported its results on Oct 16; insiders made 4 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 17 · filed 1 day later
Since the trade −2.7% · S&P 500 −5.8% · to Nov 20
Bought 12% below the 52-week high, RSI 44
An Arrow Financial director paid $100K out of pocket for Arrow Financial shares. It was the first purchase in 12 months. Shares held went up 31% with this purchase.
Lately at Arrow Financial: it reported its results on Oct 29.
Insider buying
3 insiders in a week, 3rd time since 2017Traded Nov 16 · filed 2 days later
Since the trade −3.0% · S&P 500 −6.8% · to Nov 20
Bought 30% below the 52-week high, RSI 51, 17% under its 200-day average, 13 points behind the S&P 500 over 3 months
A Tpg Re Finance Trust director paid $225K out of pocket for Tpg Re Finance Trust shares. 3 other people at Tpg Re Finance Trust bought some too, in the same month.
Lately at Tpg Re Finance Trust: it reported its results on Oct 26; the stock is up 9% in 30 days; insiders made 7 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
2 days before resultsTraded Nov 17 · filed 1 day later
Since the trade −11.0% · S&P 500 −5.8% · to Nov 20
Bought 21% below the 52-week high, RSI 69, 27% above its 200-day average, 87 points ahead of the S&P 500 over 3 months
A major shareholder of San Juan Basin Royalty Trust paid $1.48M out of pocket for San Juan Basin Royalty Trust shares. Shares held went up 6% with this purchase.
Lately at San Juan Basin Royalty Trust: the stock rose 17% in one session on Nov 10; it reported its results on Nov 19; the stock is up 29% in 30 days.
Insider buying
5 insiders in a week, 2nd time since 2006Traded Nov 17 · filed 1 day later
Since the trade −12.3% · S&P 500 −5.8% · to Nov 20
Bought 85% below the 52-week high, RSI 28, 75% under its 200-day average, 69 points behind the S&P 500 over 3 months
A Perspective Therapeutics director paid $21K out of pocket for Perspective Therapeutics shares. 4 other people at Perspective Therapeutics bought some too, in the same month. Shares held went up 88% with this purchase.
Lately at Perspective Therapeutics: the stock fell 29% in one session on Oct 23 around a company release; it reported its results on Nov 9; the stock is down 67% in 30 days.
Insider buying
Traded Nov 17 · filed 1 day later
Since the trade −4.5% · S&P 500 −5.8% · to Nov 20
Bought 38% below the 52-week high, RSI 25, 18% above its 200-day average
The CEO of Atlassian paid $828K out of pocket for Atlassian shares.
Lately at Atlassian: the stock fell 16% in one session on Nov 6 around a company release; it changed a top executive or board member on Nov 5; the stock is down 40% in 30 days.
Insider buying
First insider buy since Nov 2018Traded Nov 17 · filed 1 day later
Since the trade +3.1% · S&P 500 −5.8% · to Nov 20
Bought at the 52-week low, RSI 32, 16% under its 200-day average, 17 points behind the S&P 500 over 3 months
The CEO of Ellington Financial paid $107K out of pocket for Ellington Financial shares. 1 other person at Ellington Financial bought some too, in the same month. Shares held went up 10% with this purchase.
Lately at Ellington Financial, Inc.: it reported its results on Nov 4; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.